Literature DB >> 29426768

O6C-20-nor-salvinorin A is a stable and potent KOR agonist.

Shun Hirasawa1, Min Cho1, Tarsis F Brust2, Jeremy J Roach1, Laura M Bohn2, Ryan A Shenvi3.   

Abstract

Salvinorin A (SalA) is a potent and selective agonist of the kappa-opioid receptor (KOR), but its instability has frustrated medicinal chemistry efforts. Treatment of SalA with weak bases like DBU leads to C8 epimerization with loss of receptor affinity and signaling potency. Here we show that replacement of C20 with H and replacement of O6 with CH2 stabilizes the SalA scaffold relative to its C8 epimer, so much so that epimerization is completely supressed. This new compound, O6C-20-nor-SalA, retains high potency for agonism of KOR.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Conformational analysis; Heck reaction; Kappa opioid receptor; Salvinorin; Total synthesis

Mesh:

Substances:

Year:  2018        PMID: 29426768      PMCID: PMC6067998          DOI: 10.1016/j.bmcl.2018.01.055

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

Review 1.  Salvinorin A analogs as probes in opioid pharmacology.

Authors:  Thomas E Prisinzano; Richard B Rothman
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

2.  Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.

Authors:  Thomas A Munro; Mark A Rizzacasa; Bryan L Roth; Beth A Toth; Feng Yan
Journal:  J Med Chem       Date:  2005-01-27       Impact factor: 7.446

3.  Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics.

Authors:  Cullen L Schmid; Nicole M Kennedy; Nicolette C Ross; Kimberly M Lovell; Zhizhou Yue; Jenny Morgenweck; Michael D Cameron; Thomas D Bannister; Laura M Bohn
Journal:  Cell       Date:  2017-11-16       Impact factor: 41.582

Review 4.  Salvinorin A: a novel and highly selective kappa-opioid receptor agonist.

Authors:  Feng Yan; Bryan L Roth
Journal:  Life Sci       Date:  2004-10-15       Impact factor: 5.037

5.  Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.

Authors:  Bryan L Roth; Karen Baner; Richard Westkaemper; Daniel Siebert; Kenner C Rice; SeAnna Steinberg; Paul Ernsberger; Richard B Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

6.  8-epi-Salvinorin B: crystal structure and affinity at the kappa opioid receptor.

Authors:  Thomas A Munro; Katharine K Duncan; Richard J Staples; Wei Xu; Lee-Yuan Liu-Chen; Cécile Béguin; William A Carlezon; Bruce M Cohen
Journal:  Beilstein J Org Chem       Date:  2007-01-09       Impact factor: 2.883

7.  The Difference a Single Atom Can Make: Synthesis and Design at the Chemistry-Biology Interface.

Authors:  Dale L Boger
Journal:  J Org Chem       Date:  2017-10-13       Impact factor: 4.354

8.  Dynamic Strategic Bond Analysis Yields a Ten-Step Synthesis of 20-nor-Salvinorin A, a Potent κ-OR Agonist.

Authors:  Jeremy J Roach; Yusuke Sasano; Cullen L Schmid; Saheem Zaidi; Vsevolod Katritch; Raymond C Stevens; Laura M Bohn; Ryan A Shenvi
Journal:  ACS Cent Sci       Date:  2017-12-13       Impact factor: 14.553

  8 in total
  4 in total

1.  The quest for supernatural products: the impact of total synthesis in complex natural products medicinal chemistry.

Authors:  Zhi-Chen Wu; Dale L Boger
Journal:  Nat Prod Rep       Date:  2020-11-10       Impact factor: 13.423

2.  Intermolecular Heck Coupling with Hindered Alkenes Directed by Potassium Carboxylates.

Authors:  Tucker R Huffman; Yebin Wu; Alexis Emmerich; Ryan A Shenvi
Journal:  Angew Chem Int Ed Engl       Date:  2019-01-25       Impact factor: 15.336

Review 3.  Chemical syntheses of the salvinorin chemotype of KOR agonist.

Authors:  Sarah J Hill; Aurélien U C M Brion; Ryan A Shenvi
Journal:  Nat Prod Rep       Date:  2020-11-18       Impact factor: 13.423

Review 4.  Natural Products for the Treatment of Pain: Chemistry and Pharmacology of Salvinorin A, Mitragynine, and Collybolide.

Authors:  Soumen Chakraborty; Susruta Majumdar
Journal:  Biochemistry       Date:  2020-09-22       Impact factor: 3.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.